Product Information
IBUPROFEN 100 MG/5 ML SUSP is a generic product labeled by Strides Pharma Inc., priced at $0.0323 per ML under NDC 64380099703. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on May 27, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/5mL
Manufacturer
Strides Pharma Inc.NDC
64380099703
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA215311FDA Approved
5/27/2022
TE Code
AB
On Market Since
9/19/2023
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 100 MG/5 ML SUSP has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 20.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0323 per ML |
|---|---|
| All-time high | $0.0433 (Jul 10, 2024) |
| All-time low | $0.0323 (Aug 19, 2026) |
| 52-week high | $0.0415 |
| 52-week low | $0.0323 |
| Median price | $0.0398 |
| Average price | $0.0394 |
| Largest weekly change | -11.3% (Jul 17, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 100 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 100 MG/5 ML SUSP, manufactured by Strides Pharma Inc., is $0.0323 per ML (NDC 64380099703), effective Aug 19, 2026.
How has the price of IBUPROFEN 100 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has declined 20.5%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 100 MG/5 ML SUSP?
Since Apr 17, 2024, the NADAC for IBUPROFEN 100 MG/5 ML SUSP has ranged from a low of $0.0323 (Aug 19, 2026) to a high of $0.0433 (Jul 10, 2024), with a median of $0.0398 per ML.
Are there cheaper alternatives to IBUPROFEN 100 MG/5 ML SUSP?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 26% below IBUPROFEN 100 MG/5 ML SUSP.
Who manufactures IBUPROFEN 100 MG/5 ML SUSP?
IBUPROFEN 100 MG/5 ML SUSP (NDC 64380099703) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.